For over 50 years, cannabis research has been limited to marijuana from one federal-approved facility in Mississippi.
The DEA now states that more companies can provide marijuana for research, eliminating obstacles to learning about the medical properties of narcotics.
“For example, I think it was difficult for (National Institute of Substance Abuse) (at least its program) to keep up with that trend, as the potency of street products increased to 12% 15%,” said Dr. Igor Grant. I will. Director of the Medical Cannabis Research Center at the University of California, San Diego.
Grant also states that it is difficult for a single company to keep up with the demand from researchers across the country.
He also said the new DEA policy would increase the diversity of research products. Previously, researchers could…